Overview

Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients

Status:
Recruiting
Trial end date:
2021-04-10
Target enrollment:
Participant gender:
Summary
efficacy and safety of Sofosbuvir containing regimens in treatment of COVID-19 Egyptian patients,
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Ledipasvir
Ribavirin
Sofosbuvir